Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Marsolais said ´300 is a VERY GOOD dose
View:
Post by palinc2000 on Feb 27, 2022 2:24pm

Marsolais said ´300 is a VERY GOOD dose

Here are his exact words from the transcripts


Christian Marsolais

Yeah, what we mentioned is that we have seen some monthly DLT [indiscernible] in 420 mg/m2. We reduced the dose to 300 20 mg/m2, which is 1.5 times the dose of docetaxel but given were administered alone, then this is a very good dose. And now we're proceeding with this study enrolling three patients looking at DLT and is following three patients. After that, we'll be ready to open the basket trial. At this stage, based on the data that we have, we're not expecting any DLTs of 300 but that will be known in the next two, three months.

Comment by palinc2000 on Feb 27, 2022 3:40pm
More ftom the transcripts   Okay, on TH1902, again, how serious were the adverse events in the cycles after the initial cycle? Paul Levesque Christian? Christian Marsolais Yeah, what we've seen is our adverse events are linked to when you get a higher dose of docetaxel. At some point you get [indiscernible] or go higher to a certain level. And what you see with docetaxel, they ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities